본문으로 건너뛰기
← 뒤로

Predicting and Monitoring Immune Checkpoint Inhibitor Therapy Using Artificial Intelligence in Pancreatic Cancer.

International journal of molecular sciences 2024 Vol.25(22)

Yu G, Zhang Z, Eresen A, Hou Q, Amirrad F, Webster S, Nauli S, Yaghmai V, Zhang Z

📝 환자 설명용 한 줄

Pancreatic cancer remains one of the most lethal cancers, primarily due to its late diagnosis and limited treatment options.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Yu G, Zhang Z, et al. (2024). Predicting and Monitoring Immune Checkpoint Inhibitor Therapy Using Artificial Intelligence in Pancreatic Cancer.. International journal of molecular sciences, 25(22). https://doi.org/10.3390/ijms252212038
MLA Yu G, et al.. "Predicting and Monitoring Immune Checkpoint Inhibitor Therapy Using Artificial Intelligence in Pancreatic Cancer.." International journal of molecular sciences, vol. 25, no. 22, 2024.
PMID 39596108

Abstract

Pancreatic cancer remains one of the most lethal cancers, primarily due to its late diagnosis and limited treatment options. This review examines the challenges and potential of using immunotherapy to treat pancreatic cancer, highlighting the role of artificial intelligence (AI) as a promising tool to enhance early detection and monitor the effectiveness of these therapies. By synthesizing recent advancements and identifying gaps in the current research, this review aims to provide a comprehensive overview of how AI and immunotherapy can be integrated to develop more personalized and effective treatment strategies. The insights from this review may guide future research efforts and contribute to improving patient outcomes in pancreatic cancer management.

MeSH Terms

Humans; Pancreatic Neoplasms; Artificial Intelligence; Immune Checkpoint Inhibitors; Immunotherapy

같은 제1저자의 인용 많은 논문 (5)